Reviewer Board
Members of the reviewer board are selected from all Cancers reviewers for regularly providing timely high quality reports on submitted manuscripts. Responsibilities of reviewers are available here.
Members
Asper Clinical Research Institute & Office of Clinical Research, St. Boniface Hospital, Winnipeg, MB R2H 2A6, Canada
Interests: oncology; research; Pharmacology; ethics; cancer; cardiology; diabetes; Innovation; regulatory
Interests: oncology; research; Pharmacology; ethics; cancer; cardiology; diabetes; Innovation; regulatory
QIMR BErghofer Medical Research Institute, Brisbane, QLD 4006, Australia
Interests: cbpr; breast cancer; training; community; partnership; health disparities; environment
Interests: cbpr; breast cancer; training; community; partnership; health disparities; environment
Department of Molecular Imaging, Princess Margaret Cancer Centre, University Health Network, Toronto, ON M5G 1L7, Canada
Interests: molecular imaging; intravital imaging; animal models; radiation biology; cancer hallmarks; tumor microenvironment; oncology; metastasis; hypoxia
Interests: molecular imaging; intravital imaging; animal models; radiation biology; cancer hallmarks; tumor microenvironment; oncology; metastasis; hypoxia
Department of Clinical Medicine, University of Copenhagen, Blegdamsvej 3B, 2200 Copenhagen, Denmark
Interests: prognostic models; head and neck squamous cell carcinoma; tumor heterogeneity; functional imaging
Interests: prognostic models; head and neck squamous cell carcinoma; tumor heterogeneity; functional imaging
Department of Surgical Oncology, Medical University of Lublin, 20-080 Lublin, Poland
Interests: surgical oncology; gastrointestinal surgery; gastric cancer; colorectal cancer; staging laparoscopy; lymph node metastases
Interests: surgical oncology; gastrointestinal surgery; gastric cancer; colorectal cancer; staging laparoscopy; lymph node metastases
1. Department of Inorganic, Physical and Colloidal Chemistry, Tashkent Pharmaceutical Institute, Oybek Street 45, Tashkent 100015, Uzbekistan
2. Department of Physics and Chemistry, Tashkent Institute of Irrigation and Agricultural Mechanization Engineers, Kori Niyoziy 39, Tashkent 100000, Uzbekistan
3. Department of Physics, National University of Uzbekistan, Tashkent 100174, Uzbekistan
4. Institute of Material Sciences, Academy of Sciences, Chingiz Aytmatov 2b, Tashkent 100084, Uzbekistan
5. College of Engineering, Akfa University, Kichik Halqa Yuli Street 17, Tashkent 100095, Uzbekistan
Interests: plasma medicine; plasma oxidation; RONS; binding free energy; immunogenic cell death; molecular dynamics
2. Department of Physics and Chemistry, Tashkent Institute of Irrigation and Agricultural Mechanization Engineers, Kori Niyoziy 39, Tashkent 100000, Uzbekistan
3. Department of Physics, National University of Uzbekistan, Tashkent 100174, Uzbekistan
4. Institute of Material Sciences, Academy of Sciences, Chingiz Aytmatov 2b, Tashkent 100084, Uzbekistan
5. College of Engineering, Akfa University, Kichik Halqa Yuli Street 17, Tashkent 100095, Uzbekistan
Interests: plasma medicine; plasma oxidation; RONS; binding free energy; immunogenic cell death; molecular dynamics
Moffitt Cancer Center and Research Institute, 12902, Magnolia Drive, Tampa, FL 33612, USA
Interests: proteomics; phosphoproteomics; cell signaling; disease biomarkers; genomics; proteogenomics; translational research; cancer; stem cell biology, pluripotency; diabetes
Interests: proteomics; phosphoproteomics; cell signaling; disease biomarkers; genomics; proteogenomics; translational research; cancer; stem cell biology, pluripotency; diabetes
Centre for Clinical Research, The University of Queensland, Herston, Brisbane, QLD 4029, Australia
Interests: cancer; genomics; pathology; molecular pathology; precision oncology
Interests: cancer; genomics; pathology; molecular pathology; precision oncology
IPATIMUP/I3S, Institute of Molecular Pathology and Immunology, University of Porto, Porto, Portugal
Interests: ovarian cancer; peritoneal dissemination; malignant ascites; molecular pathology; histopathology; protein biomarkers
Interests: ovarian cancer; peritoneal dissemination; malignant ascites; molecular pathology; histopathology; protein biomarkers
Department of Neurosurgery, University Medical Center Hamburg-Eppendorf, 20246 Hamburg, Germany
Interests: extracellular vesicles; glioma; neurosurgery; methylation; brain metastasis
Interests: extracellular vesicles; glioma; neurosurgery; methylation; brain metastasis
Radboud University Medical Centre, Nijmegen, The Netherlands
Interests: cancer chemoresistance; multidrug resistance; drug transporters; nuclear receptors; extracellular vesicles; exosomes; purinergic signaling
Interests: cancer chemoresistance; multidrug resistance; drug transporters; nuclear receptors; extracellular vesicles; exosomes; purinergic signaling
Biodonostia Health Research Institute, San Sebastian, Spain
Interests: non-alcoholic fatty liver disease (nafld); liver cancer; Hepatocellular Carcinoma; Cholangiocarcinoma; Molecular pathogenesis; therapeutic targets; molecular and cellular biology; mirnas; biomarkers
Interests: non-alcoholic fatty liver disease (nafld); liver cancer; Hepatocellular Carcinoma; Cholangiocarcinoma; Molecular pathogenesis; therapeutic targets; molecular and cellular biology; mirnas; biomarkers
Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
Interests: melanoma, drug resistance, immunotherapy
Interests: melanoma, drug resistance, immunotherapy
Ragon Institute of MGH, MIT and Harvard University, 400 Technology Square, Cambridge, MA, USA
Interests: HIV; influenza; SARS-CoV2; COVID-19; AIDS; B cell receptor sequencing; immunity; vaccination
Interests: HIV; influenza; SARS-CoV2; COVID-19; AIDS; B cell receptor sequencing; immunity; vaccination
Institute of Pathology, Oncological Pathology Group, Hospital of the RWTH Aachen University, Pauwelsstr. 30, 52074 Aachen, Germany
Interests: epigenetics; (epi)genetic biomarkers; class-II tumor suppressor genes; cancer metastasis; tumor microenvironment; drug development
Interests: epigenetics; (epi)genetic biomarkers; class-II tumor suppressor genes; cancer metastasis; tumor microenvironment; drug development
Unit of Pharmaceutics and Biopharmaceutics, Université libre de Bruxelles (ULB), 50-1050 Brussels, Belgium
Interests: inhalation; controlled-release; nanomedicine; Dry-powder for inhalation (DPI); nose-to-brain delivery; chemotherapy; oncology; lung cancer
Interests: inhalation; controlled-release; nanomedicine; Dry-powder for inhalation (DPI); nose-to-brain delivery; chemotherapy; oncology; lung cancer
Mathieu Roumiguie Department of Urology CHU/IUCT Oncopole Toulouse, 31076 Toulouse, France
Interests: diagnosis of proastate cancer; bladder cancer; urothelial carcinoma
Interests: diagnosis of proastate cancer; bladder cancer; urothelial carcinoma
Department of Health Sciences, University of Florence, Viale Pieraccini, 6, 50139 Florence, Italy.
Interests: oncology; genito-urinary cancer; gastro-intestinal cancer; immunotherapy
Interests: oncology; genito-urinary cancer; gastro-intestinal cancer; immunotherapy
Brain Tumour Research Centre, University of Wolverhampton, Wulfruna Street, Wolverhampton WV1 1LY, UK
Interests: GBM therapeutics; molecular signature of GBM; 3D culture; immunosuppression in GBM
Interests: GBM therapeutics; molecular signature of GBM; 3D culture; immunosuppression in GBM
Department of Onco-Hematology, A.O. Papardo, 98158 Messina, Italy
Interests: cancer biomarkers; ctdna; immunotherapy; liquid biopsy; Non-small cell lung cancer; targeted therapies
Interests: cancer biomarkers; ctdna; immunotherapy; liquid biopsy; Non-small cell lung cancer; targeted therapies
Hudson Institute of Medical Research, Monash University, Melbourne, VIC, Australia
Interests: cytokine biology; lung cancer; KRAS; ADAM proteases; inflammation
Interests: cytokine biology; lung cancer; KRAS; ADAM proteases; inflammation
German Cancer Research Center, Heidelberg, 69120 Heidelberg, Germany
Interests: nuclear medicine; PET/CT; PET/MRI; radiopharmaceuticals; oncological imaging; multiple myeloma; melanoma; prostate cancer
Interests: nuclear medicine; PET/CT; PET/MRI; radiopharmaceuticals; oncological imaging; multiple myeloma; melanoma; prostate cancer
Feinberg School of Medicine, Northwestern University, Chicago, IL, USA
Interests: tumor signaling and microenvironment; oncogene; cellular stress; ER stress; kinases; DNA damage response; immunotherapy; targeted therapy
Interests: tumor signaling and microenvironment; oncogene; cellular stress; ER stress; kinases; DNA damage response; immunotherapy; targeted therapy
Department of Pathology, Michigan Medicine, University of Michigan, Ann Arbor, MI 48109, USA
Interests: epigenetics; gene expression; leukemia; transcriptomics; chipseq; molecular biology
Interests: epigenetics; gene expression; leukemia; transcriptomics; chipseq; molecular biology
Boonshoft School of Medicine, Wright State University, 3640 Colonel Glenn Hwy, Dayton, OH 45435, USA
Interests: cacner; cancer therapeutics; lipid mediator; oxidative stressors; anti-tumor immune response; naturally occurring dietary compounds; cancer chemoprevention; cell signaling and apoptotic pathways
Interests: cacner; cancer therapeutics; lipid mediator; oxidative stressors; anti-tumor immune response; naturally occurring dietary compounds; cancer chemoprevention; cell signaling and apoptotic pathways
Otolaryngology-Head and Neck Surgery, University of Tokyo, Tokyo 113-8655, Japan
Interests: head and neck cancer; hpv; oropharyngeal carcinoma; hypopharyngeal carcinoma; biomarker
Interests: head and neck cancer; hpv; oropharyngeal carcinoma; hypopharyngeal carcinoma; biomarker
Department of Oncology, University Hospital of Modena and Reggio Emilia, 41125 Modena, Italy
Interests: biliary cancer; Cholangiocarcinoma; pancreatic cancer; gastric cancer; immunotherapy; organoids; clinical trials; ctdna; liquid biopsy; translational research
Interests: biliary cancer; Cholangiocarcinoma; pancreatic cancer; gastric cancer; immunotherapy; organoids; clinical trials; ctdna; liquid biopsy; translational research
Laboratory of Translational Research, Azienda Unità Sanitaria Locale-IRCCS di Reggio Emilia, 42122 Reggio Emilia, Italy
Interests: lung cancer; thyroid cancer; melanoma; HDAC inhibitors; BET inhibitors; drug resistance; CRISPR/Cas9 screening; hippo
Interests: lung cancer; thyroid cancer; melanoma; HDAC inhibitors; BET inhibitors; drug resistance; CRISPR/Cas9 screening; hippo
Department of Oncology, Georgetown University, Washington, DC 20057, USA
Interests: personalized medicine; immune checkpoints inhibitors; liver cirrhosis; Hepatocellular Carcinoma; nonalcoholic steatohepatitis; proteogenomics; bio-marker; glycosylation
Interests: personalized medicine; immune checkpoints inhibitors; liver cirrhosis; Hepatocellular Carcinoma; nonalcoholic steatohepatitis; proteogenomics; bio-marker; glycosylation
Swiss Institute for Experimental Cancer Research, EPFL, CH-1015 Lausanne, Switzerland
Interests: metastasis; tumor microenvironment; cancer stem cells; extracellular matrix; breast cancer; prostate cancer; obesity; lymphoma
Interests: metastasis; tumor microenvironment; cancer stem cells; extracellular matrix; breast cancer; prostate cancer; obesity; lymphoma
